CVS Caremark extends tender offer for Longs

WOONSOCKET, R.I. CVS Caremark announced that it has extended the expiration for its tender offer to purchase all of the outstanding common stock of Longs Drug Stores at a price of $71.50 per share in cash, until 9:00 p.m., EST, on Thursday, Oct. 16. All other terms and conditions of the tender offer remain unchanged.

Tom Ryan, chairman, president and ceo of CVS Caremark said, “As we previously stated, CVS Caremark’s offer of $71.50 per share is our best and final offer. It has cleared all regulatory hurdles, is fully financed and ready to close. We look forward to completing our merger with Longs and welcoming our Longs colleagues to the CVS Caremark family.”